Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Transcripts

Read transcripts of webcasts and audiocasts

Transcripts

Read transcripts of webcasts and audiocasts

All regions
Sweden
Finland
Denmark
Norway
Latest
Trending
Followed

Apotea, Webcast, Q1'25

By Inderes5/8/2025, 7:30 AM
Apotea

Disclaimer: This is a machine-generated transcript and may contain inaccuracies.

Sarah Ahnström
00:00 - 00:33

Good morning, everyone, and welcome to the presentation of Apotea's first quarter report. And we are presenting here today from our office in Stockholm. We will start with a fairly short presentation and the business update. And then we will move on to a Q&A session with spoken questions. And today's presenters will be Pär Svärdson, our CEO and co-founder, Johan Mårild, our CFO, and myself. Sarah Ahnström, CEO and Deputy CEO. And we will start by highlighting some quarterly highlights.

Pär Svärdson
00:34 - 00:47

Good morning, everyone, and welcome to the presentation of Apotea's first quarter report. Um, we have had a good quarter. We have experienced improved profitability and stable growth. And, um, yeah. Moving on to the next point. Let's look at the figures.

Johan Mårild
00:47 - 01:03

Good morning, everyone, and welcome to the presentation of Apotea's first quarter report. We had revenues of 1,754,000,000 in the quarter and a solid growth of 15.2%. We increased the EBIT margin from 4.1% in Q1 2024 to 5.3%. First quarter.

Pär Svärdson
01:06 - 01:49

And if we look at the quarter, we can see increased market uncertainty. Um, it's obvious for everyone in the world, but the market is a little bit unstable. But we live in a very stable part of the market. If we look back, over the last 25 years, the market has been growing every year. So, in both the good times and in times of crisis, the market has shown stability. So, it's stable. And we had solid growth driven by underlying demand. Uh, and we have also increased our market shares and improved profitability. So actually we are a little bit above our corridor now, but, um, it's been sunny.

Sarah Ahnström
01:51 - 02:14

Uh, during the quarter, we also focused quite a lot on the preparations for the new fulfillment center in Varberg. Uh, we're happy to see that everything is still proceeding according to plan, and our plan is still to go live during this summer. We are currently finalizing our testing of the automation, I should say, and starting to also recruit key personnel for the warehouse.

Johan Mårild
02:14 - 06:24

Yes, and with the solid growth in the quarter, we're now approaching 6.8 billion in rolling 12 months net revenues and a rolling 12 months adjusted EBIT margin of 4.7%. We didn't have any items affecting comparability in the quarter. Last year, we had non-recurring items of 24 million, and those costs were related to the IPO in December. Let's focus on the growth for the quarter. As mentioned, we had growth of 15.2%. We had more or less equal growth in Rx as well as in OTC and traded goods. Hence, you can see that the product mix in the quarter is in line with what it was a year ago. Go. The growth was primarily driven by a solid and stable underlying market demand, and also affected by the fact that Easter took place after the end of the period. To the right you can see our gross margin development. We had a fairly stable gross margin, slightly increased, and that increase is due to improved purchasing terms. We were able to increase our profitability in Q1 compared to Q1 24. Ebit increased from 62 million to 92 million, and the margin uplift is the result of the increased profitability, the increased gross margin, and also continued tight cost control, cost management, and an increased capacity utilization. In line with what we've said before, in line with earlier communication, we expect our costs related to Varberg to gradually increase as we start production there this summer and ramp up the organization on site. You see, our costs and depreciation as a percentage of net revenue have been going down year over year. As you can see, personnel costs in relation to sales decreased from 8.6% to 7.5%. And that decrease was the result of increased efficiency. And also, today we are using external staffing to a larger extent than a year ago, meaning that we're shifting costs from personnel costs to other operating costs. We increased our operating cash flow from 78 million in Q1 2024 to 123 million in Q1 2025. The operating cash flow financed the investments in the period of 117 million, and that investment was mainly related to our new fulfillment center in Varberg, and the increased operational cash flow was due to the increased profitability. To the right, you see a breakdown of net working capital inventory. Inventory turnover was 8.7 times and slightly increased from a year ago. The net working capital will fluctuate over time and there will be variations from quarter to quarter. Finally, let's have a look at the balance sheet and some balance sheet ratios. Um, to the left you can see our return on capital employed. Return on capital employed was close to 34% and increased from a year ago due to the increased profitability. We maintain a solid balance sheet and a low net debt despite our investments in Varberg. As of the end of Q1, we had a net debt to EBITDA ratio of 0.2.

Pär Svärdson
06:27 - 07:46

And if we look a little bit ahead, our aim will be to continue building the pharmacy of tomorrow and improve the customer experience. And with a new warehouse in Varberg, we will absolutely do that because then we can deliver same day to the West Coast. But to continue to improve the customer offering is very, very important for us, but also to build efficiency, improve the efficiency, and lower our costs. Um, but we also live in an uncertain world. And then we have a significant war ongoing in Europe. We have a trade war going on in the world and several other conflicts. So we focus quite a lot on our own security, especially cybersecurity. But we also look into maybe increasing the stock levels a little bit. So we are taking steps to reduce the risk of product shortfalls and are also reviewing the total organization. So we are really prepared for uncertain times. Um, but to work with all this and continue to increase efficiency is very important.

Sarah Ahnström
07:47 - 09:31

Yes. And as we said in the beginning, we are making preparations for the Varberg fulfillment center. Uh, everything is proceeding according to plan. And once, I think for this quarter as well, or the coming months, our focus is, of course, the launch of the new fulfillment center and also the ramp-up of the new fulfillment center. So once that is up and running, we will see an increased capacity of around 50%. So we'll go from approximately 100,000 orders a day to approximately 150,000 orders each day. And the go live is planned this summer. We're also very, very close to launching a new hub in the south of Stockholm near Oslo. And this is, of course, according to our plan to increase the capacity. And we also think it's a good location to attract and recruit pharmacists living in the south of Stockholm. And finally, I think we should also mention perhaps technology. We have used technology since the start to optimize our business and truly achieve efficiency gains. And we have talked a lot in the past two presentations about AI and the new AI department. And I think we are super happy to see that a few new AI products are being launched, and we feel quite confident that this will help us improve the optimization of operations and enhance the customer offering going forward. So, good steps. I think, uh, that was also the last slide of this quite short presentation. We will now open up for Q&A with spoken questions. So let's start.

Operator
09:35 - 09:38

A question comes from Johan Fred from SEB. Please go ahead.

Johan Fred
09:40 - 10:18

Yes. Good morning, guys. Thank you for taking my questions. Uh, a first one on, uh, the gross margin development. Could you elaborate on the drivers behind the gross margin improvement? You state that the improvements come as a result of purchasing terms. But I also note the decent growth in your service offering. Um, so, potentially a bit of a mix there as well. And also, if you could elaborate on your private label selection and how that has impacted the gross margin. Um, that would be very helpful. Thank you.

Johan Mårild
10:18 - 10:50

Yes, the gross margin is fairly stable, but as you mentioned, it's also slightly increased. And it's due to our long-term efforts to improve the purchasing terms, as well as our supplier and purchasing agreements, which is, of course, a combination of the purchasing prices and other contributions from our suppliers. And that mix is important; it is what's driving the increased gross margin somewhat.

Pär Svärdson
10:52 - 11:14

And our own products have a much higher gross margin compared to other products. So they will also help to increase. And we have launched approximately 30 new products, I believe. And um, we sell more and more of them. So, they will absolutely contribute going forward.

Johan Mårild
11:14 - 11:18

But it's still a small share of the total revenues.

Johan Fred
11:20 - 11:25

And how much of your revenue was generated from your own brands during Q1?

Johan Mårild
11:26 - 11:46

I don't have that figure in front of me. As of Q4, we had roughly 1% of the sales related to our own products. This is a long-term objective for us to increase our own product sales, but it will be a long run.

Johan Fred
11:49 - 11:58

Got it. Did you, without quoting any specific numbers, see sequential growth from Q4?

Johan Mårild
11:59 - 12:04

We see solid and very good growth in our own products.

Johan Fred
12:06 - 12:32

Thank you for taking my questions. Thank you. And the second question on sort of your contingency preparation, you state that this may affect your inventory levels over the course of the year. Uh, how should we think about this in terms of. Net working capital? Are you planning to build up or stack up on inventory or how should we interpret the comment?

Pär Svärdson
12:33 - 13:14

Yeah, I think we shall, um, I mean, uh, we're not sure we're going to do that, but we, we like, say we might do that because if we see that there's a risk of logistics problems around the world, we might add some inventory. Um, but you might never notice it because it might be just within a quarter or so. Or if we see bigger problems, we might add maybe 100 million SEK to the stock or something like that, but we're not sure because we keep an eye on the newspapers, see what happens, and follow it very closely.

Johan Fred
13:16 - 13:32

Are you planning to build up or stack up on inventory, or how should we interpret the comment? Got it, got it. Very clear. Uh, and the final one from me on sort of sales and your hiring of, uh, pharmacists. Uh, is there any way you could disclose how many pharmacists you currently have on staff?

Sarah Ahnström
13:33 - 13:55

Uh, I think we said the last time that our goal or ambition for the full year is approximately 200 pharmacists. And I would say that we are steadily recruiting towards that ambition. Uh, so I think we have quite a few new colleagues joining us every week. And we're super happy to see that we can attract pharmacists to our business. So a steady, consistent growth in the number.

Johan Mårild
13:57 - 14:04

We launched in southern Stockholm.

Sarah Ahnström
14:04 - 14:05

Exactly.

Johan Fred
14:07 - 14:11

Yes. Are you planning to build up or stack up on inventory, or how should we interpret the comment? Very clear. Thank you so much for taking the time, guys. Those were all my questions. Thank you.

Sarah Ahnström
14:11 - 14:12

Are you planning to build up or stack up on inventory, or how should we interpret the comment?

Operator
14:16 - 14:20

The next question comes from Frederick Iverson from ABG. Please go ahead.

Frederick Iverson
14:22 - 14:44

Thank you. Good morning, guys. Uh, a few questions from me as well. Uh. Good morning. Uh, can we come back to the gross margin and the improved purchasing prices that you, uh, you mentioned? Uh, do you expect the positive impact from this over the coming quarters as well, or is it more isolated to Q1?

Pär Svärdson
14:45 - 15:03

I mean, our goal is to have a stable gross margin. Uh, so we are not, like, promising an increasing gross margin, and it's going a little bit up and a little bit down. So, uh, but I think it's better that you calculate with a quite stable gross margin instead of increasing.

Frederick Iverson
15:06 - 15:16

But regarding those improved purchasing prices, is that impact isolated? Do you expect that to be a continuous driver of the gross margin?

Pär Svärdson
15:17 - 15:38

Um, we will absolutely continue to negotiate with our suppliers and try to engage them. But on the other side, we have a growing segment that has a slightly lower gross margin, so we can compensate with that. So our goal is to have a stable one.

Frederick Iverson
15:40 - 15:53

Yeah. Yeah. That's clear. Uh, do you expect the positive impact from this over the coming quarters as well, or is it more isolated to Q1? And then the second question on the Easter impact, you mentioned it in the report and in the presentation. What's your assessment of the Easter impact in Q1?

Johan Mårild
15:54 - 16:17

Uh, we had Easter last year in Q1. This year it was in Q2, and we tend to have a bit slower sales during this kind of vacation period. And also, I mean, like-for-like, a positive impact in Q1, it's hard to say a precise figure of the impact of that effect. But, um.

Pär Svärdson
16:19 - 16:35

And you always have some seasonal impacts every year. I mean, you have, um, like if it's a Monday or Sunday, the last day of the month. And so it differs a little bit, but, um, it does have some impact. Absolutely.

Frederick Iverson
16:37 - 17:04

Yeah. Uh, do you expect the positive impact from this over the coming quarters as well, or is it more isolated to Q1? Fair. Uh, and last question from my side, uh, on the external staffing you mentioned, you're increasing that, uh, gradually. And I guess we can see this as a gradual decrease in the number of employees you've had during the last year or so. Uh, how should we think about this as we look ahead on a like-for-like basis?

Johan Mårild
17:06 - 17:06

Not sure.

Pär Svärdson
17:06 - 17:34

I, um, I think if we look ahead, we will probably have approximately the same number of consultants compared to our own staff in our warehouse. Um, so from now on, I think we will see a decrease in personnel. Uh, but that's more like the actual figure. Uh, now it's more like a mix of them.

Frederick Iverson
17:37 - 17:47

Right. And when you look at the cost per employee in, in sort of like, for like, terms, how has that developed during the last 12 months?

Pär Svärdson
17:48 - 17:50

It's approximately the same.

Frederick Iverson
17:52 - 17:56

Approximately the same. I, um, I think if we look ahead, we will probably have approximately the same number of consultants compared to our own staff in our warehouse. Excellent. That's all my questions. Thank you.

Unknown 1
17:56 - 17:56

The number of consultants compared to our own staff in the warehouse is expected to remain approximately the same.

Operator
18:00 - 18:04

The next question comes from Victor Hanson from Carnegie. Please go ahead.

Victor Hanson
18:06 - 18:25

Yes. Thank you. And hi, Sarah and Johan. A couple of questions from my side. Firstly, I noticed that other products bounced back up to 15% growth versus 9% in Q4. So, did you do anything differently this time, or what do you think drove this?

Pär Svärdson
18:26 - 18:42

No, I think, I mean, if you look at the quarter, it's quite a short time, and it goes a little bit up and down. And so, it is not a significant difference. And I don't think it will be the same next quarter. It might be the opposite.

Victor Hanson
18:46 - 19:06

I um, I think if we look ahead, we will probably have approximately the same number of consultants compared to own staff in our warehouse. Okay. Uh, so, uh, on Varberg, I was hoping you could give a bit of an update here on whether you can provide an estimate of additional costs for Varberg coming in Q2? And is your plan still to start deliveries from July, meaning Q3?

Johan Mårild
19:07 - 19:41

I think the main point is that we will start ramping up the costs in connection with the start this summer, and so we will see the full impact of these costs in Q3 for sure. And what we can say and have said before is, I mean, you will start depreciation of the machinery in Varberg. And that's an investment of 350 to 380 million, which will then depreciate over five years starting from the production launch this summer. Um.

Pär Svärdson
19:42 - 20:15

Um, and if you look at the cost, I mean, now we have like five, approximately five employees in Varberg and we may add that to 10-15 during the second quarter. So, I mean, it's not a very big cost, but we are absolutely adding up some costs, but during the third quarter, we will incur much more costs. But then we also have revenues from that cost. So um, it's not big, but it's still, uh, costs coming up.

Victor Hanson
20:17 - 20:39

Yeah. Yeah. But that's, uh, that's helpful in giving the magnitude of the number of employees. Uh, so that's helpful. Uh, and a final question from my side. Uh, if you could give an update on parallel import here in Q1 and also going forward, uh, we have the stronger CAC currently. So perhaps your parallel import could benefit from this.

Sarah Ahnström
20:41 - 21:11

Uh, yes. I think we can say that we have really focused on this area for the fall and going forward. And I think we can anticipate an ongoing impact from it. Uh, I wouldn't say quarter to quarter is a quite short period still, but we are focusing on this area and we will see that it will have an effect in the long term to do a good job in this, in this area. But of course, thank you.

Victor Hanson
21:11 - 21:12

That's all for me.

Sarah Ahnström
21:12 - 21:20

It is one factor that affects us, of course, but also the availability in the market and so on. So it's different factors and parameters that mix. Yeah.

Victor Hanson
21:24 - 21:24

And what we can say and have said before is, I mean, you will start depreciation of the machinery in Varberg. And what we can say and have said before is, I mean, you will start depreciation of the machinery in Varberg.

Operator
21:27 - 21:31

The next question comes from Daniel Schmidt from Danske. Please go ahead.

Daniel Schmidt
21:33 - 22:17

Ah, yes. Good morning. Uh, and I have a couple of questions from my side. I think you mentioned that you were above the corridor that you've been guiding for when it comes to EBIT margin, impressively so in the quarter. And at the same time, you're saying that you expect the gross margin to be stable going forward. Uh, and you're also highlighting that you will take on higher depreciations from the summer when it comes to Varberg, maybe a little bit more cost. But given the growth that you're seeing, do you think that Q1 was an anomaly in terms of profitability and that they will go back down due to the factors that I just mentioned? When you look ahead.

Pär Svärdson
22:18 - 22:37

Um, I think the first quarter was a good quarter. Um, because we have said 3 to 5 and now we're a little bit above five. Um, so we want to continue to guide you within the 3 to 5 range. Um, so that's the answer.

Daniel Schmidt
22:42 - 22:54

So, are you basically saying that what's coming up is going to reduce the outperformance compared to your own corridor that you had in Q1 in the upcoming quarters? Is that a fair assumption?

Pär Svärdson
22:55 - 23:00

Um, yeah. At least we don't want to guide you on something above five.

Daniel Schmidt
23:03 - 23:17

I think you mentioned that you were above the corridor that you've been guiding for when it comes to EBIT margin, impressively so in the quarter. Okay, cool. And then in the background, you continue to gain market share. When you look at the entire market, you've been trailing online growth. As I look at it, for now, it's been three quarters. What is the reason for that?

Pär Svärdson
23:18 - 23:54

Um, I think if you look at the total market, we are increasing our market share on the total market, on the e-commerce market. Uh, if the physical chains move on volume from offline to online, or if they don't, I don't really care about that. For us, it's important that we grow, and we grow our market share of the total market. So that's what we focus on.

Daniel Schmidt
23:55 - 23:57

I think you mentioned that you were above the corridor that you've been guiding for when it comes to EBIT margin, impressively so in the quarter. Thank you very much. That's all for me.

Unknown 1
23:58 - 23:59

I think you mentioned that you were above the corridor that you've been guiding for when it comes to EBIT margin, impressively so in the quarter.

Operator
24:04 - 24:08

The next question comes from IK Ulm. Please unmute your microphone.

Johan Mårild
24:20 - 24:22

Hello. Any questions from? Okay.

Sarah Ahnström
24:24 - 24:30

I think you're still on mute if you want to try. To unmute.

Unknown 1
24:39 - 24:39

Oh.

Sarah Ahnström
24:43 - 25:00

We'll give you a moment, perhaps, okay. Please unmute if you want to ask questions. Otherwise, that was it for today's session. Thank you very much for listening in. Our next quarterly report will be released on the 18th of July, and we wish you all a pleasant day. Thank you for listening.

Pär Svärdson
25:00 - 25:01

Thank you very much.

Unknown 2
25:01 - 25:01

Take care. Bye.

Continue to the webcast
Pierce Group, Audiocast, Q3'26
Language: English11/13/2026, 8:00 AM
Göran Dahlin Good morning, everyone, and welcome to Pierce Group's presentation of our Q3 2026 interim results. Next slide, please. I am Göran Dahlin, CEO of Pierce Group, and I am with Fredrik Kjellg…
Surgical Science Sweden, Audiocast, Q3'26
Language: English11/12/2026, 10:00 AM
Tom Englund Hi everyone, and welcome to this earnings call for Surgical Science for the third quarter of 2026. My name is Tom Englund. I am the CEO. And with me today is our CFO, Anna Ahlberg. I wil…
ExpreS2ion Biotech – Presentation of Q3 2026 Interim Report
Language: English11/12/2026, 9:00 AM
ExpreS2ion is expected to release its Q3 2026 interim report on 12 November 2026. Later the same day at 10.00, ExpreS2ion’s CEO Bent U. Frandsen and CFO Keith Alexander will present the results and answer questions in a live online event.
Meko Services AB, Q3'26
Language: English11/12/2026, 8:00 AM
Pat Thank you. Good morning, and welcome to MEKO's presentation of the third quarter of 2026. I am here with our CFO, Christy Johansson, and I will begin with an overview of the quarter and some of th…
WeSports Group, Audiocast, Q3'26
Language: English11/12/2026, 8:00 AM
Unknown 1 It. Ted Sporre Welcome to our Q3 release presentation. As you know, we have already shared preliminary figures for sales and EBITDA for this quarter, but today we complete the picture. We wi…
Nordrest Holding, Audiocast, Q3'26
Language: Swedish11/12/2026, 8:00 AM
Thomas Dahlstedt Hej och välkomna! Vi ska idag presentera Nordrests senaste kvartal och tillika resultatet för perioden. Jag som pratar nu heter Thomas Dahlstedt och är grundare och tillika VD för bol…
Karnov Group, Audiocast, Q3'26
Language: English11/12/2026, 8:00 AM
Pontus Bodelsson Welcome, everyone, to Karnov Group's earnings conference, where we will present the outcome of the third quarter of 2026. Please go to slide two. I am Pontus Bodelsson, President and…
Fasadgruppen Group, Audiocast, Q3'26
Language: English11/12/2026, 7:15 AM
Magnus Blomberg Perfect. Good morning and welcome to the Fasadgruppen presentation of our results for the third quarter 2026. My name is Magnus Blomberg. You have met me before. I am the CFO of Fasadg…
Munters AB, CMD
Language: English11/11/2026, 1:00 PM
Lena Dauvergne Good. Good afternoon everyone, and a warm welcome to Stockholm, to ESSEX and to Montage Capital Markets Day 2026. Montage Capital Markets Day 2026. It is really good to see so many of y…
Cinclus Pharma, Audiocast, Q3'26
Language: English11/11/2026, 1:00 PM
Christer Ahlberg Thank you. Hello and welcome to the Cinclus Pharma third quarter 2026 earnings call. I am Christer Ahlberg, CEO of Cinclus Pharma, and with me today is our CFO, Magnus Christensen. We…
Proact IT, CMD
Language: English11/11/2026, 12:30 PM
Unknown 1 The world of data is constantly changing. Breaches are rising, and attacks are getting more advanced. Regulation drives the need for data sovereignty. Data has to be available. Critical busi…
Ferronordic AB, Audiocast, Q3'26
Language: English11/11/2026, 9:00 AM
Henrik Good morning, everyone, and welcome to our presentation of the third quarter of 2026. During the quarter, we saw higher earnings, and growing aftermarket revenue was up 15% to 1.2 billion Swedi…
BICO, Audiocast, Q3'26
Language: English11/11/2026, 9:00 AM
Anders Fogelberg Good morning, everyone, and welcome to BICO's earnings call for the third quarter of 2026. I am Anders Fogelberg, President and CEO of BICO. And joining me today is our Group CFO, Ewa…
Catena Media, Audiocast, Q3'26
Language: English11/10/2026, 5:00 PM
Manuel Stan Good afternoon. Good evening, everyone. Welcome to the Catena Media Q3 Interim Report. I am Manuel Stan and today I'm joined by our Chief Financial Officer, Michael Gerrow. Today we will b…
Ellos Group, Q3'26
Language: English11/10/2026, 8:00 AM
Hans Ohlsson Live. Good morning, everyone, and welcome to the second presentation for Ellos Group as a listed company. We have 45 minutes today for the presentation. And there is a hard stop. After th…
Scandic Hotels Group, Audiocast, Q3'26
Language: English11/10/2026, 8:00 AM
Jens Mathisen Thank you so much, and good morning, everyone, and thank you for joining us for the Q3 presentation. I am Jens Mathisen, CEO of Scandic. And joining me is our CFO, Pierre Carstensen. We…
Svevik Industri, Q3'26
Language: Swedish11/6/2026, 9:00 AM
Johan Hårdén Tack så mycket! Hello and welcome to this hearing regarding the Q3 2026 interim report. We have an agenda where we intend to introduce ourselves to all the new shareholders as well. Kort…
Attendo, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
Martin Tivéus Good morning, everyone, and thank you for joining us. Today, we will present our results for the third quarter of 2026. I am pleased to announce that this is the strongest quarter for At…
Cavotec, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
David Pagels Good morning and welcome to Cavotec's Q3 2026 presentation. I am David Pagels, the CEO of Cavotec. And together with me today, I have our new CFO, Christoffer Robertsson. I would like to…
Fractal Gaming Group, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
Jonas Good morning, everyone, and welcome to Fractal's Q3 2026 presentation. Today, we'll take you through our results, the progress that we've made, and our priorities ahead after a difficult first h…